SCHEMBL465477

SCHEMBL465477

COc1ccc2[nH]c(-c3ccc(OCCCCCCCOc4ccc(-c5nc6cc(OC)ccc6[nH]5)cc4)cc3)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.56
ALDH1A1 P00352 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
PKM P14618 2/20 0.56
KDM4E B2RXH2 2/20 0.56
RAB9A P51151 2/20 0.56
TP53 P04637 2/20 0.54
HPGD P15428 2/20 0.54
MEN1 O00255 1/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
KMT2A Q03164 1/20 0.54
PLG P00747 2/20 0.54
PLAU P00749 2/20 0.54
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
HSD17B10 Q99714 1/20 0.53
SLC2A1 P11166 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13305849 0.83 TRPV1 (0.55) PLGPLAUACHEHDAC3HDAC4
SCHEMBL465479 0.82 ACHE (0.54) NPC1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL21017614 0.82 ACHE (0.65) ALDH1A1KDM4EPLGPLAUACHE
SCHEMBL6262977 0.82 NPC1 (0.79) NPC1ALDH1A1SMN1; SMN2PKMKDM4E
SCHEMBL3337335 0.82 NPC1 (0.60) NPC1ALDH1A1SMN1; SMN2PKMKDM4E
SCHEMBL2324292 0.81 NPC1 (0.78) NPC1ALDH1A1SMN1; SMN2PKMKDM4E
SCHEMBL419326 0.81 NPC1 (0.71) NPC1ALDH1A1SMN1; SMN2PKMKDM4E
SCHEMBL1170729 0.81 ALDH1A1 (0.57) NPC1ALDH1A1SMN1; SMN2PKMKDM4E
SCHEMBL20982723 0.81 CHEK2 (0.61) PLGPLAUACHEHDAC3HDAC4
SCHEMBL21017228 0.81 ACHE (0.66) ALDH1A1KDM4EPLGPLAUACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194981-B1 BISBENZIMIDAZOLES AS ANTIMALARIAL AGENTS UNIV MONS HAINAUT (BE) 2011-11-23 EP disclosed
US-20100160402-A1 Bisbenzimidazoles as antimalarial agents XAVIER UNIVERSITY OF LOUISIANA 2010-06-24 US disclosed
US-20100160402-A1 Bisbenzimidazoles as antimalarial agents XAVIER UNIVERSITY OF LOUISIANA 2010-06-24 US disclosed
US-20100160402-A1 Bisbenzimidazoles as antimalarial agents XAVIER UNIVERSITY OF LOUISIANA 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160402-A1 Bisbenzimidazoles as antimalarial agents NQO2, SQOR, CPS1 NPC1 1415/4885ALDH1A1 2545/4885SMN1; SMN2 3993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.